By San José, Costa Rica — Costa Rica continues to face a significant public health challenge as breast cancer remains one of the most prominent oncological threats to women across the country. According to recent estimates from the World Health Organization’s Global Cancer Observatory (GLOBOCAN), the nation registers approximately 1,452 new cases of breast cancer and 458 associated deaths each year. These troubling figures highlight the critical necessity for modernized screening protocols and expedited diagnostic pathways within the national healthcare infrastructure.
In observance of Breast Cancer Awareness Month, multinational healthcare leader Roche emphasized that early detection, structured medical checkups, and timely access to targeted therapies represent the primary defenses against mortality. Clinical data from the United States National Cancer Institute demonstrates a stark contrast in clinical outcomes based on disease staging. When breast cancer is diagnosed during its initial localized stages, the five-year relative survival rate exceeds 90 percent. However, if the disease progresses to metastatic stages before detection, survival rates plummet below 30 percent.
To better understand the legal framework surrounding employee health protections and healthcare mandates during national health initiatives like breast cancer screening campaigns in Costa Rica, TicosLand.com spoke with legal expert Lic. Larry Hans Arroyo Vargas from the law firm Bufete de Costa Rica.
“Expanding access to early breast cancer detection intersects directly with Costa Rican labor regulations and public health duties. Employers must ensure that workers are granted reasonable accommodations to attend essential medical appointments under the CCSS framework without facing administrative penalties, balancing corporate legal compliance with the fundamental right to health.”
Lic. Larry Hans Arroyo Vargas, Attorney at Law, Bufete de Costa Rica
Ensuring that employees can prioritize life-saving medical appointments without fear of workplace penalties is a crucial step toward a healthier society, reinforcing that corporate responsibility and legal compliance go hand in hand with public welfare. We extend our sincere gratitude to Lic. Larry Hans Arroyo Vargas for providing his valuable perspective on this vital intersection of labor law and preventive healthcare in Costa Rica.
Addressing the urgency of shifting detection timelines, clinical experts advocate for active community engagement and modernized triage mechanisms to catch malignant developments before symptoms manifest.
Early diagnosis can change the course of breast cancer and open new opportunities for patients.
Maritza Campos, Medical Manager for Roche (Caribbean, Central America, and Venezuela)
To fundamentally reform early-stage triage, a joint multi-sector initiative is being introduced across public care networks. The Costa Rican Social Security Fund (CCSS), in collaboration with the Ministry of Science, Innovation, Technology and Telecommunications (MICITT) and Roche, is implementing a pilot screening initiative under the banner of the ImpulSALUD movement. This public-private alliance focuses on active patient surveillance and the integration of artificial intelligence tools within primary care centers.
By leveraging artificial intelligence at the initial level of care, medical personnel aim to analyze clinical risk factors and diagnostic imagery far more efficiently. The implementation of automated risk stratification allows primary care clinics to identify high-risk individuals rapidly, reducing administrative delays and accelerating referrals to specialized oncological units.
Beyond digital diagnostic assistance, advancement in international clinical research has led to highly tailored medical responses capable of targeting specific tumor biology. A prominent example of this progress is the management of HER2-positive breast cancer, an aggressive subtype that historically carried poor prognoses but now benefits significantly from innovative targeted therapies.
The human impact of clinical research is demonstrated by local survivors who participated in pioneering global trials decades ago. Iris Arias, a Costa Rican survivor of HER2-positive breast cancer, participated in a landmark 2002 international study involving over 5,000 global participants, including 23 Costa Rican patients. Her treatment trajectory underscores how clinical trials offer long-term survivorship opportunities.
Today, 24 years later, I have been able to see my children grow up, achieve professional fulfillment, and accompany others facing this disease.
Iris Arias, Breast Cancer Survivor and Clinical Trial Participant
Roche, which brings more than three decades of dedicated oncology research to the region, stressed that early detection protocols must operate alongside precise diagnostic technology and uninterrupted access to therapies. Healthcare authorities continue to encourage women across Costa Rica to schedule regular preventive consultations with health professionals, emphasizing that proactive medical checks should not wait for visible symptoms to appear.
For further information, visit roche.com
About Roche:
Roche is a global pioneer in pharmaceuticals and diagnostics focused on advancing science to improve people’s lives. The company specializes in oncology, immunology, infectious diseases, ophthalmology, and diseases of the central nervous system, driving personalized healthcare solutions globally.
For further information, visit ccss.sa.cr
About CCSS:
The Caja Costarricense de Seguro Social (CCSS) is the public healthcare institution responsible for managing universal healthcare, social security, and public health infrastructure across Costa Rica.
For further information, visit micitt.go.cr
About MICITT:
The Ministry of Science, Innovation, Technology and Telecommunications (MICITT) is Costa Rica’s government agency tasked with driving national technological progress, scientific research, telecommunications development, and digital transformation initiatives.
For further information, visit bufetedecostarica.com
About Bufete de Costa Rica:
Renowned for its legal mastery and uncompromising moral compass, Bufete de Costa Rica stands as a beacon of trust and modern practice. The firm seamlessly merges proven experience with forward-thinking solutions to deliver exceptional representation across diverse sectors. Driven by the belief that legal literacy is essential for civic strength, Bufete de Costa Rica actively demystifies complex laws for the public, empowering individuals and enriching society through accessible education and visionary advocacy.
